Evidence map›Paper›PMID 29232408›Full record

ArticlePloS one2017

Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.

Amna Malik, Emily Adland, Leana Laker, Henrik Kløverpris, Rabiah Fardoos, Julia Roider, Mai C Severinsen, Fabian Chen, Lynn Riddell, Anne Edwards and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Amna MalikDepartment of Paediatrics, University of Oxford, Oxford, United Kingdom.ORCID http://orcid.org/0000-0002-5325-3453
Emily AdlandDepartment of Paediatrics, University of Oxford, Oxford, United Kingdom.
Leana LakerKimberley General Hospital, Kimberley, South Africa.
Henrik KløverprisAfrica Health Research Institute, AHRI, Durban, South Africa.
Rabiah FardoosAfrica Health Research Institute, AHRI, Durban, South Africa.
Julia RoiderAfrica Health Research Institute, AHRI, Durban, South Africa.
Mai C SeverinsenLaboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Fabian ChenDepartment of Sexual Health, Royal Berkshire Hospital, Reading, United Kingdom.
Lynn RiddellDepartment of Genitourinary Medicine, Northamptonshire Healthcare NHS Trust, Northampton General Hospital, Northampton, United Kingdom.
Anne EdwardsOxford Department of Genitourinary Medicine, the Churchill Hospital, Oxford, United Kingdom.
Søren BuusLaboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Pieter JoosteKimberley General Hospital, Kimberley, South Africa.
Philippa C MatthewsNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Philip J R GoulderDepartment of Paediatrics, University of Oxford, Oxford, United Kingdom.
University of Copenhagen · DKUniversity of Oxford · GBKimberley Hospital · ZAAfrica Health Research Institute · ZAChurchill Hospital · GBNorthampton General Hospital NHS Trust · GBRoyal Berkshire Hospital · GB

Funding

Optimizing CD8+ T-cell responses against C clade HIV infection in subSaharan AfriR01AI046995 · NIAID · UNIVERSITY OF OXFORD · PI GOULDER, PHILIP J · 2000 to 2014
$6.8M
NIAID NIH HHS R01 AI046995Wellcome Trust
6 · The paper itself

Abstract

More than 90% of children in Africa are infected with cytomegalovirus (CMV) by the age of 12 months. However, the high-frequency, immunodominant CD8+ T-cell responses that control CMV infection have not been well studied in African populations. We therefore sought to define the immunodominant CMV-specific CD8+ T-cell responses within sub-Saharan African study subjects. Among 257 subjects, we determined the CD8+ T-cell responses to overlapping peptides spanning three of the most immunogenic CMV proteins, pp65, IE-1 and IE-2, using IFN-γ ELISpot assays. A bioinformatics tool was used to predict optimal epitopes within overlapping peptides whose recognition was statistically associated with expression of particular HLA class I molecules. Using this approach, we identified 16 predicted novel CMV-specific epitopes within CMV-pp65, IE-1 and IE-2. The immunodominant pp65-specific, IE-1, IE-2 responses were all either previously well characterised or were confirmed using peptide-MHC tetramers. The novel epitopes identified included an IE-2-specific epitope restricted by HLA*B*44:03 that induced high-frequency CD8+ T-cell responses (mean 3.4% of CD8+ T-cells) in 95% of HLA-B*44:03-positive subjects tested, in one individual accounting for 18.8% of all CD8+ T-cells. These predicted novel CMV-specific CD8+ T-cell epitopes identified in an African cohort will facilitate future analyses of immune responses in African populations where CMV infection is almost universal during infancy.

Indexed as

AdultAfrica South of the SaharaCD8-Positive T-LymphocytesCohort StudiesCytomegalovirusEnzyme-Linked Immunosorbent AssayFemaleHumansImmunodominant EpitopesMaleYoung AdultImmunodominant Epitopes

Identifiers

PMID29232408
PMCPMC5726643
OpenAlexW2773811028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.